IBSA USA
Leon Lombard is a specialty pharmaceutical sales representative at IBSA USA, specializing in endocrinology and pain management since August 2022. Prior to this role, Leon demonstrated exceptional sales capabilities at Sales Focus Inc., where performance consistently exceeded quotas, achieving a 147% growth in territory and a company-high of 677 new transactions in the first month. Leon's diverse experience includes pastoral roles, such as College & Young Professionals Pastor and Middle School Student Minister at Cottonwood Creek Church, and early career positions in marketing and medical billing. Leon holds a Bachelor of Science in Psychology (Pre-Med) from Texas A&M University and is currently pursuing a Master of Divinity at Southwestern Baptist Theological Seminary.
This person is not in any teams
IBSA USA
IBSA USA is the subsidiary of IBSA Group, the largest privately owned pharmaceutical company in Switzerland. IBSA is committed to improving patient quality of life through research, innovation, and the development of effective drugs and cutting-edge technologies. IBSA USA markets two unique levothyroxine formulations in the U.S. for the treatment of hypothyroidism: Tirosint® (levothyroxine sodium) capsules and Tirosint®-SOL (levothyroxine sodium) oral solution. IBSA also markets Licart™ (diclofenac epolamine) topical system 1.3%, the only once-a-day topical nonsteroidal anti-inflammatory (NSAID) available in the U.S. to treat acute pain due to minor strains, sprains, and contusions. IBSA is focused on the health and well-being of patients and driven by the desire to bring therapeutic alternatives to as many people as possible. IBSA Group bases its philosophy on four sustainable pillars: Person, Innovation, Quality, and Responsibility. For more information about Tirosint, Tirosint-SOL, or Licart, including Full Prescribing Information, go to each brand’s respective website.